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Available online 3 August 2016Drug use is associatedwith increased sexual risk behaviors.We examinedwhether decreases in drug use risk are
associated with reduction in HIV-related sex risk behaviors among adults. Data was from a cohort of participants
(n = 574) identiﬁed by drug use screening in a randomized trial of brief intervention for drug use in an urban
primary care setting. Inverse probability of treatment weighted (IPTW) logistic regression models were used
to examine the relationship between decreases in drug use risk and sex-related HIV risk behavior reduction
from study entry to six months. Weights were derived from propensity score modeling of decreases in drug
use risk as a function of potential confounders. Thirty seven percent of the study participants (213/574) reported
a decrease in drug use risk, and 7% (33/505) reported decreased sex-related HIV risk behavior at the six-month
follow-up point. We did not detect a difference in reduction of risky sexual behaviors for those who decreased
drug use risk (unadjusted: OR 1.32, 95% CI 0.65–2.70; adjusted OR [AOR] 1.12, 95% CI 0.54–2.36). Adults who
screened positive for high drug use risk had greater odds of reducing sex risk behavior in unadjusted analyses
OR 3.71, 95% CI 1.81–7.60; but the results were not signiﬁcant after adjusting for confounding AOR 2.50, 95% CI
0.85–7.30). In this primary care population, reductions in HIV sex risk behaviors have complex etiologies and re-
ductions in drug use risk do not appear to be an independent predictor of them.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Sex risk behavior
Unprotected sex
Drug use
HIV/AIDS1. Introduction
More than three decades after the ﬁrst cases of human immunodeﬁ-
ciency virus (HIV) infections were reported, HIV transmission remains a
serious public health problem. The Centers for Disease Control and
Prevention (CDC) estimates that there are approximately 50,000 newly
infected persons each year, with the majority of infections resulting
from unprotected sexual contact (Centers for Disease Control and
Prevention, CDC, 2013a, 2014). Racial and ethnic minority groups, partic-
ularly, Black/African Americans, are disproportionately affected by the
HIV/AIDS epidemic, more so than any other racial or ethnic minority
group (Centers for Disease Control and Prevention, CDC, 2015, 2016). Al-
cohol and other drug use are considered important risk factors for thelth, College of Health Sciences,
venue, Southwick Hall 328K,
r).
. This is an open access article undertransmission of sexually transmitted infections (STIs) including HIV
(Centers for Disease Control and Prevention, CDC, 2013b; Metrik et al.,
2016; Raj et al., 2009; Shuper et al., 2009; Vagenas et al., 2015). The pri-
mary pathway is thought to be reduction in inhibition and reasoning abil-
ity with concomitant increase in sex risk behaviors such as unprotected
sexual intercourse, havingmultiple sex partners, and participation in sur-
vival and transactional sex (Hedden et al., 2011; Justus et al., 2000;
MacDonald et al., 2000).
Drug use is associatedwith sex risk behaviors including non- and in-
consistent condom use, having multiple sex partners, and unprotected
transactional sex (sex for drugs or money), (Bonar et al., 2014; Booth
et al., 1993, 2000; Broz et al., 2014; Hedden et al., 2011). Marijuana
use is a contributing factor in HIV risk behaviors (Anderson and Stein,
2011; Hittner and Kennington, 2008), with users more likely to report
multiple sexual partners (Valera et al., 2009). Further, Marijuana users
are at increased risk of sexually acquiring HIV (Fernandez et al., 2004)
and other sexually transmitted diseases (De Genna et al., 2007).
Cocaine and opiate using populations are at greater risk for HIV
infection (Booth et al., 2000; Metzger et al., 1993), and are more likelythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2000). Interventions addressing drug use have the potential to mitigate
negative health consequences andHIV related risk behaviors such as sex
risk (Henry-Edwards et al., 2003; Saitz et al., 2010). HIV prevention ef-
forts speciﬁc to at-risk adult populations have shown an effect in reduc-
ing HIV related risk behaviors (Copenhaver et al., 2006; Crepaz et al.,
2007; Herbst et al., 2005, 2007; Johnson et al., 2002; Neumann et al.,
2002; Semaan et al., 2002). Prevention interventions in sexually trans-
mitted disease (STD) clinics (Kamb et al., 1998), outpatient based drug
treatment facilities (Woody et al., 2003) and inpatient addiction treat-
ment settings (Samet et al., 2008) have an effect on decreasing HIV
risk behaviors. However, HIV risk assessments and risk reduction inter-
ventions are seldom applied in primary care settings (Wenrich et al.,
1997). Little is known about the relationship between decreases in
drug use and reduction in sex risk behaviors among adults in primary
care settings.
Primary care clinicians and practitioners can play a vital role in facil-
itating HIV-risk related behavior change for individuals at risk for HIV
and other STIs. Primary care settings are thought to provide an impor-
tant opportunity to identify and deliver interventions to reduce drug
use (Bernstein et al., 2005; Babor et al., 2007; Humeniuk et al., 2012;
Saitz, 2014). Brief interventions that identify and address drug use be-
haviors in primary care settings have the potential to reduce drug use
and subsequent consequences. For example, addressing drug use during
a brief intervention could directly or indirectly motivate individuals to
reduce involvement in sex risk behaviors (e.g. condom use, reducing
the number of sex partners). However, limited data exist about the rela-
tionship between decreases in drug use and reduction in sex risk behav-
iors among drug using adults who are engaged in brief interventions in
primary care settings.
We sought to examine whether decreases in drug use risk are asso-
ciated with reductions in HIV sex risk behaviors among adults who
screened positive for drug use, and those with high drug use severity
(consistent with dependence). We hypothesized that decreases in
drug use risk are associated with reductions in HIV sex risk behaviors
for adults who screened positive for drug use, as well as those with
drug dependence.
2. Materials and methods
Data originated from theAssessing Screening Plus Brief Intervention's
Resulting Efﬁcacy to Stop Drug Use (ASPIRE) study, a 3-group
randomized controlled trial of two brief interventions for unhealthy
drug use among adult patients in an urban primary care setting, that
did not detect differences by type of intervention (Saitz et al., 2014).
Details about the assessments, interventions and randomization are pre-
viously reported (Saitz et al., 2014 including supplementary online
content).
2.1. Study population
Our analysis sample was comprised of adults 18 years or older who
were enrolled and randomized in the ASPIRE study, and who also
completed the 6 month follow-up interview (n = 574). Participants
were enrolled in the study (n = 589) if they screened positive for past
3-month drug use on the Alcohol, Smoking, and Substance Involvement
Screening Test (ASSIST) (Humeniuk et al., 2008). For this analysis, we
included all study participants who reported a total ASSIST score of 2
or greater at baseline, indicating some drug use at least once in the
past 3 months. This measure allowed for the opportunity to assess re-
duction in drug use for participants who engaged in low to high drug
use risk levels. Note: Saitz et al., 2014 reports only results among partic-
ipantswith ASSIST scores of 4 or greater indicatingweekly ormore drug
use in the past three months, with drug use ranging from moderate to
high risk levels (Humeniuk et al., 2008; Saitz et al., 2014).2.2. Measures
2.2.1. Outcome
Reduction in HIV sex risk behaviors (yes vs. no), the primary out-
come of this study, was deﬁned based on whether a subject reported
fewer unsafe sex practices at the 6-month follow-up compared to base-
line. The number of unsafe sex practices at each time point was deter-
mined based on condom use and other sex risk behaviors response
items. Study participants completed assessments of HIV sex risk and
drug use risk behaviors in the past three months (Navaline et al.,
1994) using an audio-computer-assisted self-interviewing (ACASI) sys-
tem at baseline and six month interviews. The ACASI system has been
shown to increase disclosure and veracity in responses to sensitive
and often stigmatized HIV sex risk behavior questions (Rogers et al.,
2005). Unsafe sex was operationalized as the number of times the sub-
ject self-reported non-condom use during vaginal or anal intercourse in
the past 3 months in the following scenarios: a) having sex with non-
primary partner; b) engaging in currency transactional sex (i.e., paid
money for sex or received money for sex); and c) engaging in
drug transactional sex (i.e., given drugs for sex or received drugs
for sex). We calculated the difference in total number of self-reported
unsafe sex practices at six months and baseline interview periods
(6 month minus baseline). A reduction in unsafe sex was fewer
number of unsafe sex episodes at six months. Operationalizing the out-
come as a dichotomous variable was considered more clinically inter-
pretable and relevant for these risk behaviors. The rationale for this is
that, participants reporting non-condom use with non-primary and
transactional partners during either vaginal or anal intercourse, would
be at increased the risk for HIV transmission regardless of number of
encounters.2.2.2. Independent variables
Participants were assessed for drug use risk using the Alcohol,
Smoking and Substance Involvement Screening Test (ASSIST) at base-
line and in six month follow-up interviews (Humeniuk et al., 2008).
The clinical question of interest for this study was to evaluate any de-
crease in drug use, this was considered the most clinically relevant
main independent variable. The main independent variable, decrease
in drug use risk (yes/no), was therefore operationalized as any reduc-
tion in the total ASSIST score at six month follow-up compared to base-
line (6month valueminus baseline value). Participants who indicated a
lower ASSIST score at the six month follow-up period were categorized
as “yes = decreased drug use risk” while those who had increased or
same scores at follow-up were categorized as “no= same or increased
drug use risk”. The ASSIST score identiﬁes risk of health and other prob-
lems from the participant's current pattern of use (Humeniuk et al.,
2008), therefore, the term “drug use risk” is used in this study to appro-
priately measure more than use. The choice to use the binary indepen-
dent variable allowed us to study the association between decrease in
drug use risk and decrease in sex risk in a manner that is clinically rele-
vant, rather than examining this relationship using decrease in points
on a scale such as the ASSIST that in our study ranges from 2 to 131.
In secondary analyses,we further explored the relationship between
reduction in HIV sex risk and drug use risk by examining adults who
screened positive for high drug use risk (consistent with dependence)
at study entry compared to those with low to moderate risk. We used
a binary Alcohol, Smoking, and Substance Involvement Screening Test
[ASSIST] score operationalized as ≥27 = high risk of experiencing se-
vere health, social and other problems as a result of current pattern of
use and are likely to be dependent and; ≤26 = low and moderate risk
of health and other problems. The operationalization of this measure
has a clinical and practical basis as participants with higher ASSIST
scores are thought to need drug treatment (Humeniuk et al., 2008),
and thus a threshold for tailoring interventions and treatment for indi-
viduals experiencing severe problems.
Table 1
Characteristics of study sample.
Variable n (%), mean (std. dev)
Number times unsafe sex (N = 527) 1.8 (SD 19.9)
Total ASSIST scorea 20.3 (SD 18.5)
Total ASSIST score
Total ASSIST b26 430 (74.9%)
Total ASSIST ≥27 144 (25.1%)
Randomization group
MOTIV-interventionb 189 (32.9%)
BNI-interventionc 191 (33.3%)
Intervention control 194 (33.8%)
Age 41.5 (SD 12.3)
Gender
Male 390 (67.9%)
Female 184 (32.1%)
Race/ethnicity
Black African American 397 (70.3%)
Hispanic 53 (9.4%)
White 110 (19.5%)
Other 5 (0.9%)
Main drugd
Cocaine 106 (18.5%)
Marijuana 363 (63.2%)
Opioids 94 (16.4%)
Other drug 11 (1.9%)
Number heavy drinking days 4.5 (SD 8.0)
Depression (PHQ-9 Score)
PHQ b10 381 (66.4%)
PHQ ≥10 193 (33.6%)
Homelessness (past 3 months)
Yes 89 (15.5%)
No 485 (84.5%)
High school graduate
Yes 404 (70.4%)
No 170 (29.6%)
Self-help group
Yes 94 (16.4%)
No 480 (83.6%)
Substance use disorder treatment
Yes 147 (25.7%)
No 426 (74.3%)
Support systems
Yes 509 (88.7%)
No 65 (11.3%)
Support systems = personal or family resources as social support system(s) (“Are there
people you feel you could turn to if you were feeling bad and needed someone to talk to
about something that was important to you?”). PHQ= Patient Health Questionnaire.
a The total Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) score.
b Motivational interviewing (MOTIV) enhanced intervention.
c Brief negotiated interview (BNI) standard intervention.
d Main drug” was the substance that concerned the participant the most.
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The Gelberg-Andersen Behavioral Model for Vulnerable Populations
(Gelberg et al., 2000), a revised version of the Andersen Behavioral
Health Model (Aday and Awe, 1997; Andersen, 1968, 1995) that in-
cludes domains relevant to understanding vulnerable populations
who are at higher risk for illness, was used to guide the selection of co-
variates including demographics, depression, and heavy alcohol use at
baseline, that may inﬂuence the relationship between decreases in
drug use risk and HIV sex risk reduction.
Predisposing factors: included age (18 years and older), gender (male
and female), level of education (completed high school education), and
race/ethnicity (Black/African American, White, Other, and Hispanic, re-
spectively). Due to the small sample sizes for Asian, Alaska Native, Na-
tive Hawaiian/Other Paciﬁc Islander, American Indian, these categories
were included in “Other”. Predisposing factors speciﬁc to vulnerable
populations included homelessness, meaning that the participant
spent one or more nights on the street or in an overnight shelter at
least once in the past three months.
Enabling factors: included having personal or family resources as so-
cial support system(s) (“Are there people you feel you could turn to if
you were feeling bad and needed someone to talk to about something
thatwas important to you?”); and self-help seeking skills such as partic-
ipating in a self-help group, Alcoholics Anonymous (AA), Narcotics
Anonymous (NA), Cocaine Anonymous (CA) in the past six months.
Severity and need factors: included screening positive for depression
as assessed using the Patient Health Questionnaire (PHQ-9) (Kroenke
et al., 2001); alcohol use operationalized as number of heavy drinking
days in the past month with heavy drinking deﬁned as N3 standard
drinks for women, N4 standard drinks for men in a day (National
Institute on Alcohol Abuse and Alcoholism, NIAAA, 2005); participant's
main drug at study entry, and substance use treatment operationalized
as outpatient or inpatient treatment for alcohol, drugs or mental health
in the past three months as assessed using the 90-Alcohol Intake Re-
vised Economic Data (AIR/ED) form (Miller, 1996).
2.3. Statistical analysis
To characterize the study sample, descriptive statisticswere calculated
overall and stratiﬁed by primary predictor (decrease in drug use risk). To
control for confounding in the analysis of whether decreases in drug use
risk are associatedwith reductions in HIV sex risk behaviors, we analyzed
data using inverse probability of treatment weighted (IPTW) logistic re-
gression models. First we modeled the main independent variable, de-
crease in drug use risk, using a multiple logistic regression model
adjusting for potential confounders of the association between a decrease
in drug use risk and reduction in HIV sex risk behaviors. Based on this
model, we calculated the predicted probabilities of having a decrease in
drug use risk, (i.e. the propensity score for each subject). Covariate bal-
ance was assessed in the weighted sample by assessing the standardized
differences between exposure groups, where an absolute difference of
b0.20 was considered acceptable (Lanza et al., 2013). Lastly, the propen-
sity scoreswere incorporated into the analyses using IPTW logistic regres-
sion models and robust standard errors are reported. Secondary analyses
for ASSIST score ≥27 at baseline were conducted using the same ap-
proach. Two-tailed tests and an alpha level of 0.05 were used for all
tests. Analyses were conducted using SAS version 9.3 (SAS Institute Inc.,
2011).
3. Results
Demographic characteristics of the study sample are shown in
Table 1. Of the 589 participants enrolled and randomized in the
ASPIRE study, 574 (98%) completed the six month follow-up interview
and comprise the analytic sample for this study. The average age of
study participants was 42 (SD 12.3) years. The majority of the partici-
pants were male (68%), Black or African American (70%), and reportedan education level of completed high school or more (70%). Only 16%
of the study sample reported being homeless. The main drug was mar-
ijuana (63%) with participants also reported an average of 4.5 (SD 8.0)
heavy drinking days in the past month. A quarter (26%) of the study
sample indicated utilizing either inpatient or outpatient treatment for
alcohol, drugs or mental health in the past three months; 16% had par-
ticipated in self-help groups in the past six months. While more than
three quarters of the study sample reported having some form of social
support system (89%), a substantial proportion reported moderate to
severe depression (34%). Thirty seven percent (213/574) reported
a decrease in drug use risk at the six month follow up period, and 7%
(33/505) reported a reduction in HIV sex risk behaviors. Note that 69
participants were missing data on HIV sex risk behaviors from baseline
to six months.
As shown in Table 2a, the inverse probability of treatment weighted
(IPTW) method using the propensity score resulted in acceptable bal-
ance for all covariates (i.e., all standardized differences b0.20 in absolute
value) between those who did and did not decrease drug use risk. Co-
variate balance was also achieved for the secondary analysis of ASSIST
score ≥27 vs. b27 (Table 2b).
Table 2a
Characteristics of those with decreased drug use risk vs. same or increased drug use risk (baseline to 6 months) for the unweighted and weighted samplesa.
Variable Unweighted Weighted by IPTW
Decreased drug
use risk
Drug use risk same
or higher
Standardized
differenceb
Decreased drug
use risk
Drug use risk same
or higher
Standardized
differenceb
Randomization group MOTIV-interventionc 32.9% 33.0% 0.00 32.9% 32.9% 0.00
BNI-interventiond 34.7% 32.4% 0.07 34.0% 33.7% 0.01
Intervention control 32.4% 34.6% 0.07 33.1% 33.5% 0.01
Age (mean) 41.2 41.7 0.04 41.6 41.4 0.01
Male 73.2% 64.8% 0.26 69.0% 68.3% 0.02
Race/ethnicity Black African American 64.8% 73.5% 0.26 72.0% 71.2% 0.02
Hispanic 11.4% 8.2% 0.16 9.3% 9.1% 0.01
White 22.9% 17.5% 0.19 18.2% 19.0% 0.03
Other 1.0% 0.9% 0.02 0.6% 0.7% 0.03
Main druge Cocaine 22.1% 16.3% 0.21 17.9% 18.0% 0.00
Marijuana 51.6% 70.1% 0.54 63.9% 63.5% 0.01
Opioids 22.5% 12.7% 0.37 16.3% 16.3% 0.00
Other drug 3.8% 0.8% 0.28 2.0% 2.2% 0.02
Heavy drinking days (mean) 4.3 4.7 0.05 4.5 4.6 0.00
Depression (PHQ-9 score b10) 63.4% 68.1% 0.14 67.2% 66.8% 0.01
Homeless (past 3 months) 19.3% 13.3% 0.23 15.3% 15.7% 0.01
High school graduate 68.1% 71.7% 0.11 70.2% 70.6% 0.01
Self-help group 22.1% 13.0% 0.34 15.8% 16.0% 0.01
Substance use disorder treatment 31.0% 22.5% 0.27 24.1% 24.8% 0.02
Support systems 87.3% 89.5% 0.10 89.0% 89.0% 0.00
PHQ = Patient Health Questionnaire.
a Drug use risk is measured using the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) score.
b Absolute value of standardized difference.
c Motivational interviewing (MOTIV) enhanced intervention.
d Brief negotiated interview (BNI) standard intervention.
e “Main drug”was the substance that concerned the participant the most Support systems = personal or family resources as social support system(s) (“Are there people you feel you
could turn to if you were feeling bad and needed someone to talk to about something that was important to you?”).
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weighted logistic regression model using propensity scores. As shown
in Table 3, among adults in an urban hospital primary care setting, we
did not detect a statistically signiﬁcant decrease in HIV sex risk behavior
for adults who had decreased drug use risk from baseline to six months
(unadjusted: OR 1.32, 95% CI: 0.65–2.70; AOR 1.12, 95% CI: 0.54–2.36).Table 2b
Characteristics of those with ASSIST score equal to or N27 vs. less than or equal to 26 (baseline
Variable Unweighted
Total ASSIST
≥27
To
0–
Randomization group MOTIV-interventionc 31.9% 33
BNI-interventiond 30.6% 34
Intervention control 37.5 32
Age (mean) 41.7 41
Male 70.8% 67
Race/ethnicity Black African American 54.2% 75
Hispanic 13.4% 8.0
White 31.7% 15
Other 0.7% 1.0
Main druge Cocaine 35.4% 12
Marijuana 21.5% 77
Opioids 38.2% 9.1
Other drug 4.9% 0.9
Heavy drinking days (mean) 6.5 3.9
Depression (PHQ-9 score b10) 46.5% 73
Homeless (past 3 months) 26.4% 11
High school graduate 72.9% 69
Self-help group 34.7% 10
Substance use disorder treatment 51.4% 17
Support systems 85.4% 89
PHQ = Patient Health Questionnaire.
a The total Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) score.
b Absolute value of standardized difference.
c Motivational interviewing (MOTIV) enhanced intervention.
d Brief negotiated interview (BNI) standard intervention.
e “Main drug”was the substance that concerned the participant the most Support systems =
could turn to if you were feeling bad and needed someone to talk to about something that waHowever in secondary analyses, adults who had high drug use risk at
baseline (ASSIST ≥27) appeared to have higher odds of reducing sex
risk behaviors within a six month period compared to those with
lower ASSIST scores (unadjusted OR 3.71, 95% CI 1.81–7.60, p b 0.001).
After adjusting for potential confounding factors, these differences
were not statistically signiﬁcant (AOR: 2.50, 95% CI 0.85–7.30).) for the unweighted and weighted samplesa.
Weighted by IPTW
tal ASSIST
26
Standardized
differenceb
Total ASSIST
≥27
Total ASSIST
0–26
Standardized
differenceb
.3% 0.04 39.6% 34.0% 0.16
.2% 0.11 27.2% 32.6% 0.17
.6% 0.15 33.2% 33.4% 0.01
.4 0.02 39.4 41.5 0.10
.0% 0.12 70.0% 66.8% 0.10
.7% 0.63 75.4% 72.4% 0.10
% 0.24 7.4% 8.8% 0.07
.4% 0.55 17.1% 18.0% 0.03
% 0.04 0.2% 0.9% 0.13
.8% 0.78 17.6% 19.3% 0.06
.2% 1.90 65.3% 64.0% 0.04
% 1.03 15.1% 14.6% 0.02
% 0.33 2.0% 2.1% 0.01
0.32 4.7 4.4 0.02
.0% 0.79 67.4% 66.5% 0.03
.9% 0.53 11.0% 14.1% 0.13
.5% 0.11 72.5% 69.8% 0.08
.2% 0.87 16.0% 15.7% 0.01
.0% 1.10 27.4% 25.2% 0.07
.8% 0.19 86.7% 87.9% 0.05
personal or family resources as social support system(s) (“Are there people you feel you
s important to you?”).
Table 3
Unadjusted and adjusted analyses of decrease in sex risk behavior (baseline to 6 months).
Predictors Unadjusted logistic regression n = 505 Propensity score adjusteda logistic regression n = 504
Crude OR (95% CI) p-Value Adjusted OR (95% CI) p-Value
Decreased ASSISTb (baseline to 6 months) 1.32 (0.65, 2.70) 0.45 1.12 (0.54, 2.36) 0.76
ASSIST ≥27b (baseline) 3.71 (1.81, 7.60) b0.01 2.50 (0.85, 7.30) 0.10
a Adjusted for randomization group, gender, age, race/ethnicity, main drug, number of heavy drinking days, depression (PHQ-9), homelessness, education (high school or higher), self-
help group, substance use disorder treatment and social support systems.
b Based on total Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) score.
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Brief interventions for drug use in primary care patients have the po-
tential to reduce drug use and improve health outcomes (Saitz et al.,
2010). This research provides valuable information about whether the
goal of drug use intervention in primary care settings (brief or
otherwise)—a decrease in drug use and related risks—might have an ob-
jective clinical beneﬁt, speciﬁcally, sex risk behavior reduction. Among
adults who screened positive for drug use in primary care, we did not
detect a difference in HIV sex risk behavior reduction for those who de-
creased drug use risk over a six -month period compared to those who
did not. Study ﬁndings also suggest that adults who screened positive
for high drug use risk had greater odds of reducing sex risk behavior,
but these ﬁndings were not statistically signiﬁcant in adjusted models.
Drug using adults engaging in sex risk behaviors place themselves at
increased risk for HIV infection. Certain interventions addressing drug
use behaviors have a strong impact on preventing HIV infection
(e.g., syringe exchange). However, evidence suggests that among drug
users, drug treatment (Sorensen and Copeland, 2000) and HIV preven-
tion interventions (van Empelen et al., 2003) are more effective at re-
ducing drug use and less effective at changing sex risk behaviors. For
individuals that screen positive for drug use, exposure to brief interven-
tion to reduce drug use in primary care is thought to potentially have
many beneﬁts, one ofwhich is to reduce social and health risk behaviors
such as sex risk behaviors (Henry-Edwards et al., 2003). However, expo-
sure to drug use screening and brief intervention does not necessarily
reduce drug use behavior (Saitz et al., 2014), and our ﬁndings demon-
strate that a decrease in drug use risk is not associated, in this primary
care sample, with reduced sex risk behaviors. Addressing drug use
may not be enough to change sex risk behaviors among drug users,
and therefore, one should not necessarily expect a change in sex risk be-
haviors even when individuals reduce drug use risk; other mechanisms
may be at play.
Adults with drug dependence have more negative health outcomes
and co-occurring conditions (McLellan et al., 2000) and are at greater
risk for HIV infection (Booth et al., 2000; Metzger et al., 1993). Although
not statistically signiﬁcant, our results suggest that adults with drug de-
pendence who reduce their drug use risk may have greater odds of re-
ducing sex risk behavior than those with lower ASSIST scores in
primary care settings. However, this study raises questions about
“howmuch drug use risk reduction is needed to reduce sex risk behav-
iors,” and the scope and breadth of interventions needed to affect both
drug use and sex risk behavior.
While individual drug use behaviors are an important predictor for
HIV sex risk (Bonar et al., 2014; Booth et al., 1993, 2000), our study ﬁnd-
ings call attention to recognizing factors beyond individual behavior
change in the intertwining syndemic of HIV and drug use, and how
these factors may differ by population group. For instance, our study
participants are predominantly marijuana smokers and Black/African
American, a racial and ethnic group that is disproportionately at higher
risk for HIV infection and HIV related deaths due to contextual chal-
lenges including, lack of access to health care, higher rates of other sex-
ually transmitted infections, stigma, and lack of awareness of HIV status
(Centers for Disease Control and Prevention, CDC, 2015, 2016; Seth
et al., 2013; Siddiqi et al., 2015).Whilemarijuana is a contributing factorfor HIV infection (Anderson and Stein, 2011; Hittner and Kennington,
2008), and African Americans are at greater risk for HIV infection
(Centers for Disease Control and Prevention, CDC, 2015, 2016), the eti-
ology of drug use – type of drug, route of transmission – must be ad-
dressed when designing preventive interventions to address drug use
and HIV sex risk.
Future research and interventions should be enhanced to address
the multi-dimensional nature of HIV sex risk behaviors that go beyond
individual level drug behavior change. Contextual factors including
health and social resources, social capital, social norms, physical and
neighborhood environments inﬂuence drug use and sex risk behaviors
among vulnerable populations (Galea et al., 2003). Several research
studies have noted the importance of addressing HIV risk among drug
users in the context of social and structural factors and or environments
that inﬂuence HIV risk (Rhodes, 2002, 2005; Strathdee et al., 2010;
Gupta et al., 2008). In this study, the primary care setting, an ‘enabling
environment’ for the adoption of protective behaviors in which drug
use risk decreased, did not appear to enable sex risk reduction for a vul-
nerable drug using adult population. This ﬁnding may in part be ex-
plained by the fact that participants in this study predominantly used
marijuana, a drug that is often not an independent risk factor for HIV
sex risk, whichmay limit our ability to generalize our ﬁndings about re-
ductions in sex risk behaviors to other patient populations. While pri-
mary care settings provide an important opportunity for providing
screening and brief intervention for drug use, these interventions will
need to be enhanced in order to address both drug use and HIV risk
behaviors.
This exploratory secondary analysis adds to the literature onHIV risk
reduction in the context of screening and brief intervention for drug use
in primary care for adults who are at higher risk for HIV sex risk behav-
iors and other drug use consequences. Study ﬁndings contribute to our
understanding of drug use and sex risk behaviors and clarify the paths
to consider when developing targeted interventions among this vulner-
able population in primary care settings.
5. Limitations
Our studyhas several limitations. First, this is an observational study,
which often limits the ability to draw causal inferences. However, use of
the propensity score methods in this paper allows us to estimate the
causal effect of reduced drug use risk on decreased HIV sex risk behav-
iors. Second, the number of participants reporting a decrease in sex risk
behaviors at sixmonthswas relatively small in this secondary data anal-
ysis, whichmay have limited our study power. In post-hoc power calcu-
lations, assuming 6% of those who did not decrease drug use risk at
follow-up (based on data at 6 months) had a reduction in sex risk be-
haviors, the study would have approximately 80% power to detect an
odds ratio as small as 2.6. For the secondary analysis of screening posi-
tive for drug use risk consistent with dependence, assuming 4% of
those who did not screen positive for drug use risk consistent with de-
pendence at follow-up (based on data at 6 months) had a reduction in
sex risk behaviors, the study would have approximately 80% power to
detect an odds ratio as small as 3.3. Thus the studywas likely underpow-
ered to detect effect sizes of the observed magnitudes. Despite the rela-
tively small sample size and event rate, the results of this exploratory
415A.W. Walter et al. / Preventive Medicine Reports 4 (2016) 410–416study provide useful descriptive and hypothesis generating data that
can provide useful effect size estimates for the design of larger scale
studies on this important topic. Third, the drug use measure was inclu-
sive of a wide array of drugs, and not limited to the main drug. As such,
our analysis was an aggregate effect of reduction in a range of drugs, and
did not focus on a speciﬁc drug. However, our focus on more than one
drug allowed for the examination of exposure to all drug use risk that
would not be captured by focusing on one speciﬁc drug. Fourth, this
study does not control for unmeasured confounders that may inform
the relationship between decreased drug use risk and a reduction in
sex risk behaviors. Fifth, we did not use momentary assessments of
drug use and sex risk behaviors therefore we cannot speak to
encounter-level drug and sex risk behaviors. Finally, data are obtained
by self-report and are subject to recall bias or may be underreported
or overreported.
6. Conclusions
The HIV/AIDS epidemic continues to impact many high-risk vulner-
able populations. Drug use and drug use disorders increase the likeli-
hood of HIV transmission through HIV risk behaviors, including sex
risk behaviors. Primary care settings have potential to be important av-
enues for druguse andHIV prevention efforts.Wewere unable to detect
a signiﬁcant effect of decreases in drug use risk on reductions in HIV sex
risk behaviors. One potential implication is that there is a need for a
complex approach that addresses the individual, social, structural and
environmental factors that inﬂuence HIV sex risk behaviors. The results
also raise questions about common assumptions that addressing drug
use risk in clinical settings is sufﬁcient to warrant reductions in other
health risk behaviors amongdrug users. Theseﬁndings highlight the po-
tential need for behavioral interventions that address multiple risk be-
haviors, and that go beyond reductions in drug use when addressing
drug use and disorders in primary care settings.
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